Document is current
Any future updates will be listed below
-
Authors
Go, Ronaldo C.
Nyirenda, Themba
Bojarian, Maryam
Hosseini, Davood K.
Kim, Kevin
Rahim, Mehek
Paleoudis, Elli G.
Go, Anna C.
Han, Zhiyong
Sperber, Steven J.
Gupta, Anjali
- License Information
-
More Information
Article History
Received: 2 November 2021
Accepted: 2 March 2022
First Online: 14 March 2022
Declarations
:
: Ethical approval and clearance were obtained from IRB board from participating hospitals. Approval was obtained by the Hackensack Meridian Health Institutional Review Board (#Pro2020-0485) and the study was also registered on ClinicalTrials.Gov as a prospective observational database (NCT04347993). Waiver of consent [45cfr46.116(d)] was approved by Hackensack Meridian Health Institutional Review Board and was applied due to minimal risk, waiver will not adversely affect the rights and welfare of subjects, the research could not be carried out without the waiver, and whenever possible the subjects were provided with additional pertinent information after participation. At that time, the risk is reasonable due to importance of knowledge gained. The study was conducted according to the International Conference on Harmonization (ICH), Good Clinical Practice (GCP), the Declaration of Helsinki, Institutional Review Boards (IRB) and in accordance with the U.S. Code of Federal Regulations on Protection of Human Rights (21 CFR 50).
: Not applicable.
: Dr. Ronaldo C. Go participated in a long-term follow-up committee for long term follow-up in COVID-19 patients sponsored by Hoffmann-LaRoche. All the other authors have no competing interests.
